The Patent Finder

Item Development Aktiebolag

Also on record
Records under this name other than patents Item Development Aktiebolag holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Item Development Aktiebolag

PatentTitleStatus Expires Confidence
US 5,104,859Continuous administration of adenosine to reduce pulmonary vascular resistance
Term ended
Term ended no later than Apr 14, 2012 · Low confidence
Term endedTerm ended no later than Apr 14, 2012Low confidence
US 5,231,086Continuous administration adenosine to increase myocardial blood flow
Term ended
Term ended no later than Jul 27, 2013 · Low confidence
Term endedTerm ended no later than Jul 27, 2013Low confidence
US 5,449,665Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
Term ended
Term ended no later than Sep 12, 2015 · Low confidence
Term endedTerm ended no later than Sep 12, 2015Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited